3-aminobenzamide has been researched along with dobutamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bährle, S; Beller, C; Berger, I; Dengler, TJ; Gerö, D; Hagl, S; Sivanandam, V; Stumpf, N; Szabó, C; Szabó, G | 1 |
1 other study(ies) available for 3-aminobenzamide and dobutamine
Article | Year |
---|---|
Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; Coronary Vessels; Dobutamine; Endothelial Cells; Graft Rejection; Graft Survival; Heart; Heart Transplantation; Hemodynamics; Humans; Immune System; Indoles; Lymphocyte Activation; Myocardium; Phosphates; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred Lew; Rats, Inbred Strains; T-Lymphocytes; Transplantation, Homologous; Transplantation, Isogeneic | 2006 |